151 related articles for article (PubMed ID: 35876461)
21. Safety of Plasma Infusions in Parkinson's Disease.
Parker JE; Martinez A; Deutsch GK; Prabhakar V; Lising M; Kapphahn KI; Anidi CM; Neuville R; Coburn M; Shah N; Bronte-Stewart HM
Mov Disord; 2020 Nov; 35(11):1905-1913. PubMed ID: 32633860
[TBL] [Abstract][Full Text] [Related]
22. Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor Progression.
Lim SH; Ferdousi M; Kalteniece A; Mahfoud ZR; Petropoulos IN; Malik RA; Kobylecki C; Silverdale M
Mov Disord; 2021 Aug; 36(8):1927-1934. PubMed ID: 33826165
[TBL] [Abstract][Full Text] [Related]
23. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.
Müthing J; Cacić M
Glycoconj J; 1997 Jan; 14(1):19-28. PubMed ID: 9076510
[TBL] [Abstract][Full Text] [Related]
24. Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor.
Park SY; Kwak CY; Shayman JA; Kim JH
Biochim Biophys Acta; 2012 Jul; 1820(7):1141-8. PubMed ID: 22542783
[TBL] [Abstract][Full Text] [Related]
25. Lipidomics Prediction of Parkinson's Disease Severity: A Machine-Learning Analysis.
Avisar H; Guardia-Laguarta C; Area-Gomez E; Surface M; Chan AK; Alcalay RN; Lerner B
J Parkinsons Dis; 2021; 11(3):1141-1155. PubMed ID: 33814463
[TBL] [Abstract][Full Text] [Related]
26. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
[TBL] [Abstract][Full Text] [Related]
27. Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis.
Chan RB; Perotte AJ; Zhou B; Liong C; Shorr EJ; Marder KS; Kang UJ; Waters CH; Levy OA; Xu Y; Shim HB; Pe'er I; Di Paolo G; Alcalay RN
PLoS One; 2017; 12(2):e0172348. PubMed ID: 28212433
[TBL] [Abstract][Full Text] [Related]
28. ATP-binding cassette transporters mediate differential biosynthesis of glycosphingolipid species.
Budani M; Auray-Blais C; Lingwood C
J Lipid Res; 2021; 62():100128. PubMed ID: 34597626
[TBL] [Abstract][Full Text] [Related]
29. A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009.
Thijssen E; den Heijer J; Puibert D; Moss L; Lei M; Hasegawa D; Keum K; Mochel K; Ezzeldin Sharaf M; Alfredson T; Zeng W; van Brummelen E; Naranda T; Groeneveld GJ
Mov Disord; 2022 Apr; 37(4):790-798. PubMed ID: 35048423
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Type 2 Diabetes in Parkinson's Disease.
Athauda D; Evans J; Wernick A; Virdi G; Choi ML; Lawton M; Vijiaratnam N; Girges C; Ben-Shlomo Y; Ismail K; Morris H; Grosset D; Foltynie T; Gandhi S
Mov Disord; 2022 Aug; 37(8):1612-1623. PubMed ID: 35699244
[TBL] [Abstract][Full Text] [Related]
31. Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi.
Guimarães LL; Toledo MS; Ferreira FA; Straus AH; Takahashi HK
Front Cell Infect Microbiol; 2014; 4():138. PubMed ID: 25309884
[TBL] [Abstract][Full Text] [Related]
32. GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes.
Greuel A; Trezzi JP; Glaab E; Ruppert MC; Maier F; Jäger C; Hodak Z; Lohmann K; Ma Y; Eidelberg D; Timmermann L; Hiller K; Tittgemeyer M; Drzezga A; Diederich N; Eggers C
Mov Disord; 2020 Dec; 35(12):2201-2210. PubMed ID: 32853481
[TBL] [Abstract][Full Text] [Related]
33. Self-Report versus Clinician Examination in Early Parkinson's Disease.
Zolfaghari S; Thomann AE; Lewandowski N; Trundell D; Lipsmeier F; Pagano G; Taylor KI; Postuma RB
Mov Disord; 2022 Mar; 37(3):585-597. PubMed ID: 34897818
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
[TBL] [Abstract][Full Text] [Related]
35. Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease.
Bartl M; Dakna M; Schade S; Otte B; Wicke T; Lang E; Starke M; Ebentheuer J; Weber S; Toischer K; Schnelle M; Sixel-Döring F; Trenkwalder C; Mollenhauer B
Mov Disord; 2023 Jan; 38(1):68-81. PubMed ID: 36267007
[TBL] [Abstract][Full Text] [Related]
36. Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK-PD Study).
Uyar M; Lezius S; Buhmann C; Pötter-Nerger M; Schulz R; Meier S; Gerloff C; Kuhle J; Choe CU
Mov Disord; 2022 Jun; 37(6):1299-1304. PubMed ID: 35384057
[TBL] [Abstract][Full Text] [Related]
37. Pathological role of lipid interaction with α-synuclein in Parkinson's disease.
Suzuki M; Sango K; Wada K; Nagai Y
Neurochem Int; 2018 Oct; 119():97-106. PubMed ID: 29305919
[TBL] [Abstract][Full Text] [Related]
38. Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential.
Hanisch FG; Sölter J; Jansen V; Lochner A; Peter-Katalinic J; Uhlenbruck G
Br J Cancer; 1990 Jun; 61(6):813-20. PubMed ID: 2372482
[TBL] [Abstract][Full Text] [Related]
39. Differential Regulation of Glucosylceramide Synthesis and Efflux by Golgi and Plasma Membrane Bound ABCC10.
Iqbal J; Otaibi AA; Mubarak SA; Alqarni A; Bakillah A
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678216
[TBL] [Abstract][Full Text] [Related]
40. Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease.
Heilman PL; Wang EW; Lewis MM; Krzyzanowski S; Capan CD; Burmeister AR; Du G; Escobar Galvis ML; Brundin P; Huang X; Brundin L
Mov Disord; 2020 Nov; 35(11):2028-2037. PubMed ID: 32710594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
